North America Leads Consumption of PAP and Paracetamol, Accounted for 40% of Global Market by Volume in 2013

According to a new market report published by Transparency Market Research “PAP and Paracetamol Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022”, the global PAP and paracetamol market was valued at US$0.4 bn and US$0.8 bn, respectively, in 2013 and is projected to reach US$0.7 bn and US$1.0 bn, respectively, in 2022.

Get sample report copy or for further inquiries http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6763

The report on the global paracetamol and para-aminophenol market studies the current and future prospects of the market with respect to demand, consumption, and production. Geographically, the PAP and paracetamol market has been segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Rest of the World.

North America held the largest share in terms of consumption in 2013. The paracetamol market in North America was valued at US$394.05 mn in 2013 and is projected to reach US$ 437.1 mn by 2022. The PAP market in North America was valued at US$188.9 mn in 2013. The region accounted for the largest share of 40% of the global market in term of volume in 2013. Presence of large number of PAP manufacturers and availability of technically advanced manufacturing facilities resulted in the continued dominance of North America in PAP and paracetamol production.
 
Rising awareness about the side effects and the consequent stringent regulations to ensure minimizing of these side effects could negatively affect the paracetamol market in the U.S. and Europe. Unpredictable epidemics leading to unexpected demand for paracetamol is likely to lead to higher production of paracetamol. Due to the shutdown of all the paracetamol manufacturing plants in Europe, the region is completely dependent on imports from China and India for its paracetamol requirements.
 
Asia Pacific is the largest producer of paracetamol due to the presence of large number of local manufacturers. Presence of advanced manufacturing facilities, cheap and abundant labor, developed infrastructure, availability of wide range of raw materials and intermediate products are driving paracetamol production in China. Demand for PAP in Asia Pacific stood at 65,753.9 tonnes in 2013. Government support, good manufacturing practice (GMP) certification, and regulatory norms to ensure quality of the finished product (paracetamol API) are increasing production of paracetamol API. In terms of consumption, Asia Pacific accounted for a share of 24% of the global paracetamol market in 2013. This region dominated the global paracetamol market due to large demand and rapidly expanding pharmaceutical industry that uses paracetamol for the formulation of finished products. Moreover, periodic pandemic diseases such as seasonal influenza, swine flu, malaria, and Chikungunya increase the consumption of paracetamol in countries in Asia Pacific. The anti-dumping duties imposed by some governments can lead to surplus production of paracetamol in Asia Pacific.
 
Well-defined regulatory framework, rise in investments in the pharmaceutical industry, and thereby increase in the availability of production facilities are anticipated to boost production of PAP and paracetamol API in emerging regions such as Latin America. Limited number of paracetamol API manufacturers in the region has led to increased dependency on imports from India and China. Rapidly increasing health care expenditure and availability of paracetamol without prescription at affordable price are driving the consumption of paracetamol API in RoW.

Browse the full PAP and Paracetamol Market: (Demand, Production, Consumption, and Regional): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 – 2022 report at http://www.transparencymarketresearch.com/paracetamol-market.html

Major companies operating in the global PAP and paracetamol market include Angene International Limited, BOC Sciences, Granules India, Haihang Industry Co., Ltd., Jinan Haohua Industry Co., Ltd., Kemcolour International, Mallinckrodt plc, ORGANICA Feinchemie GmbH Wolfen, Parchem Fine & Specialty Chemicals, Wuxi Feipeng Imp. & Exp. (Group) Co., Limited, and Zhejiang Hisun Chemical Co., Limited. The market displays intense competitive rivalry due to the presence of well-established global as well as domestic players. Various strategies are being adopted by the manufacturers in the industry to gain and sustain their competitive advantage. Some of the strategies include pharmaceutical collaborations, focus on improvements, and cost containment or optimization measures.

The global PAP and paracetamol market has been segmented as follows:

Global PAP Market Revenue, by Geography
North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• Rest of Europe

Asia Pacific

• Australia
• Japan
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America
• Rest of the World

Global Paracetamol Market Revenue, by Geography
North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• Rest of Europe

Asia Pacific

• Australia
• Japan
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America
• Rest of the World

About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com